SEARCH

SEARCH BY CITATION

References

  • 1
    Al-Saeed, A., Makris, M., Malia, R.G., Preston, F.E, Greaves, M. (1994) The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. British Journal of Haematology, 88, 845 848.
  • 2
    Angelucci, E. (1994) Antibodies to hepatitis C virus in thalassemia. Haematologica, 79, 353 355.
  • 3
    Bevers, E.M., Galli, M., Barbui, T., Comfurius, P, Zwaal, R.F.A. (1991) Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thrombosis and Haemostasis, 66, 629 632.
  • 4
    Brandt, J.T., Triplett, D.A., Alving, B, Scharrer, I. (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thrombosis and Haemostasis, 74, 1185 1190.
  • 5
    Camps, J., Castilla, A., Ruiz, J., Civeira, M.P, Prieto, S. (1993) Randomised trial of lymphoblastoid alfa-interferon in chronic hepatitis C: effects on inflammation, fibrogenesis and viremia. Journal of Hepatology, 17, 390 396.
  • 6
    Exner, T., Rickard, K.A, Kronenber, H. (1978) A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. British Journal of Haematology, 40, 143 151.
  • 7
    Galli, M., Barbui, T., Comfurius, P., Zwaal, R.F.A, Bevers, E.M. (1992) Anticoagulant activity of anticardiolipin antibodies is mediated by β2-glycoprotein I. Thrombosis and Haemostasis, 68, 297 300.
  • 8
    Galli, M., Beretta, G., Daldossi, M., Bevers, E, Barbui, T. (1997) Different anticoagulant properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 77, 486 491.
  • 9
    Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., De Baets, M.H., Von Breda-Vriesman, P.J.C., Barbui, T., Zwaal, R.F.A, Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet, 335, 1544 1547.
  • 10
    Gharavi, A.E., Harris, E.N., Asherson, R.A, Hughes, G.R.V. (1987) Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Annals of the Rheumatic Diseases, 6, 1 6.
  • 11
    Gotoh, M & Matsuda, J. (1995) Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of anticardiolipin antibody. American Journal of Hematology, 50, 220 222.
  • 12
    Harris, E.N., Gharavi, A.E, Hughes, G.R.V. (1991) The anticardiolipin assay. Phospholipid-binding Antibodies (ed. by E. N. Harris, T. Exner, G. R. V. Hughes and R. A. Asherson), pp. 175 182. CRC Press, Boca Raton.
  • 13
    Hunt, J.E., McNeil, H.P., Morgan, G.J., Crameri, R.M, Krilis, S.A. (1992) A phospholipid-β2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus, 1, 75 82.
  • 14
    Lai, M.E., Mazzoleni, A.P., Argiolu, F., De Virgilis, S., Balestreri, A., Purcell, R.H., Cao, A, Farci, P. (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet, 343, 388 390.
  • 15
    Loizou, S., McCrea, J.D., Rudge, A.C., Reynolds, R., Boyle, C.C, Harris, E.N. (1985) Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay: standardization and quantification of results. Clinical and Experimental Immunology, 62, 739 744.
  • 16
    Love, P.E & Santoro, S.A. (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and not-SLE disorders. Annals of Internal Medicine, 112, 682 698.
  • 17
    Matsuda, J., Saitoh, N., Gotoh, M., Gohchi, K., Tsukamoto, M., Syoji, S., Miyake, K, Yamanaka, M. (1995) High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon A. American Journal of Gastroenterology, 90, 1138 1141.
  • 18
    Matsuda, J., Saitoh, N., Tsukamoto, M., Gohchi, K., Asami, K, Hashimoto, M. (1993) Measurement of β2-glycoprotein I (apolipoprotein H)-independent anticardiolipin antibody in human immunodeficiency virus-1-positive and -negative hemophiliacs. American Journal of Hematology, 43, 146 150.
  • 19
    Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K, Koike, T. (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet, 336, 177 178.
  • 20
    Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., Suzuki, T., Sumida, T., Yasuda, T, Koiwe, T. (1992) Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. Journal of Immunology, 148, 3885 3891.
  • 21
    McNally, T., Purdy, G., Mackie, I.J., Machin, S.J, Isenberg, D.A. (1995) The use of an anti-β2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. British Journal of Haematology, 91, 471 473.
  • 22
    McNeil, H.P., Chesterman, C.N, Krilis, S.A. (1989) Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. British Journal of Haematology, 73, 506 513.
  • 23
    McNeil, H.P., Chesterman, C.N, Krilis, S.A. (1991) Immunology and clinical importance of antiphospholipid antibodies. Advances in Immunology, 49, 193 280.
  • 24
    Michaeli, J., Mittelman, M., Grisaru, D, Rachmilewitz, E.A. (1992) Thromboembolic complications in beta thalassemia major. Acta Haematologica, 87, 71 74.
  • 25
    Pierangeli, S.S., Harris, E.N., Davis, S.A, De Lorenzo, G. (1992) β2 GPI enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies. British Journal of Haematology, 82, 565 570.
  • 26
    Prieto, J., Yuste, J.R., Beloqui, O., Civeira, M.P., Riezu, J.I., Aguirre, B, Sangro, B. (1996) Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology, 23, 199 204.
  • 27
    Schwartz, R.S. (1993) Autoimmunity and autoimmune diseases. Fundamental Immunology, 3rd edn (ed. by W. E. Paul), p. 1076. Raven Press, New York.
  • 28
    Thiagarajan, P., Pengo, V, Shapiro, S.S. (1986) The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant. Blood, 68, 869 874.
  • 29
    Weiss, L., You, J.F., Giral, P., Alhenc-Gelas, M., Senger, D, Kazatchkine, M.D. (1995) Anticardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-β2-glycoprotein I antibodies in HIV infection. Clinical Immunology and Immunopathology, 77, 69 74.